放射性药物化学领域中的重要事件和研究前沿

    Important Events and New Frontiers in Field of Radiopharmaceutical Chemistry

    • 摘要: 评述了核化学和放射化学对人类健康改善的贡献。首先简要介绍了放射性的发现历史及在核化学和放射化学领域中其它与人类健康相关的重要发现。再介绍了钼-锝发生器和锝药物的研发历程、锝药物的基本原理及在核医学中的主要应用以及其它用于核医学中的重要放射性核素。其次介绍了PET药物的显像原理、18F-FDG的研发历程及在核医学中的广泛应用;还介绍了其它重要的18F标记的显像药物。然后概述了目前的放射性治疗药物,着重介绍了用于治疗骨转移瘤的223RaCl2注射液。再概述了各种模式显像技术的特点,并着重介绍了PET/MRI双模态显像药物的研发进展。最后,对核化学和放射化学在改善人类健康中的作用进行了展望,并简要叙述了中国所取得的成就和存在的问题。

       

      Abstract: The contributions of nuclear chemistry and radiochemistry to the improvements on human health were reviewed in this article. Firstly, the discovery history of radioactivity and other important discoveries, related to human health in the field of nuclear chemistry and radiochemistry, were briefly introduced. Secondly, the development history of 99Mo/99Tcm generator, the principles and major applications of 9Tcm radiopharmaceuticals as well as other major radionuclides in nuclear medicine, were described. Thirdly, the imaging principle of PET radiopharmaceuticals, the development history and the wide applications in nuclear medicine of 18F-FDG, together with other important 18F-labeled imaging agents were depicted. Fourthly, the current therapeutic radiopharmaceuticals were summarized; then, 223Ra dichloride injection for the therapy of bone metastases was highlighted. Fifthly, the advantages and disadvantages of various imaging technology were outlined; then, the new developments of PET/MRI dual-modal imaging agents were emphasized. Lastly, the roles of nuclear chemistry and radiochemistry to the improvements on human health were prospected; then, the achievements and existing problems of China were discussed.

       

    /

    返回文章
    返回